Brief: Qualigen Therapeutics Reports Q3 Loss Per Share $0.10
Nov 15 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS, INC. REPORTS THIRD QUARTER 2021
FINANCIAL
RESULTS
* Q3 REVENUE $1.2 MILLION
* Q3 LOSS PER SHARE $0.10
* BELIEVES ITS CASH AND CASH EQUIVALENTS ARE SUFFICIENT TO
FUND
ITS ANTICIPATED OPERATIONS THROUGH LATE 2022
Source text for Eikon: ID:nGNX4f0S7P
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise